BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23740247)

  • 1. The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.
    Du H; Huang Y; Zaghlula M; Walters E; Cox TC; Massiah MA
    J Biol Chem; 2013 Jul; 288(29):21341-21350. PubMed ID: 23740247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.
    Du H; Wu K; Didoronkute A; Levy MV; Todi N; Shchelokova A; Massiah MA
    PLoS One; 2014; 9(9):e107428. PubMed ID: 25207814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.
    LeNoue-Newton M; Watkins GR; Zou P; Germane KL; McCorvey LR; Wadzinski BE; Spiller BW
    J Biol Chem; 2011 May; 286(20):17665-71. PubMed ID: 21454489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of the in vitro e3 ligase activity of the human MID1 protein.
    Han X; Du H; Massiah MA
    J Mol Biol; 2011 Apr; 407(4):505-20. PubMed ID: 21296087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination.
    McConnell JL; Watkins GR; Soss SE; Franz HS; McCorvey LR; Spiller BW; Chazin WJ; Wadzinski BE
    Biochemistry; 2010 Mar; 49(8):1713-8. PubMed ID: 20092282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR studies of the C-terminus of alpha4 reveal possible mechanism of its interaction with MID1 and protein phosphatase 2A.
    Du H; Massiah MA
    PLoS One; 2011; 6(12):e28877. PubMed ID: 22194938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin-inducible EDD E3 ubiquitin ligase binds to α4 phosphoprotein to regulate ubiquitination and degradation of protein phosphatase PP2Ac.
    McDonald WJ; Thomas LN; Koirala S; Too CKL
    Mol Cell Endocrinol; 2014 Jan; 382(1):254-261. PubMed ID: 24145130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
    Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
    PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit α4, altering PP2A stability and microtubule-associated protein phosphorylation.
    Watkins GR; Wang N; Mazalouskas MD; Gomez RJ; Guthrie CR; Kraemer BC; Schweiger S; Spiller BW; Wadzinski BE
    J Biol Chem; 2012 Jul; 287(29):24207-15. PubMed ID: 22613722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XLOS-observed mutations of MID1 Bbox1 domain cause domain unfolding.
    Wright KM; Wu K; Babatunde O; Du H; Massiah MA
    PLoS One; 2014; 9(9):e107537. PubMed ID: 25216264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional observations of the P151L MID1 mutation reveal alpha4 plays a significant role in X-linked Opitz Syndrome.
    Wright KM; Du H; Massiah MA
    FEBS J; 2017 Jul; 284(14):2183-2193. PubMed ID: 28548391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha4 phosphoprotein interacts with EDD E3 ubiquitin ligase and poly(A)-binding protein.
    McDonald WJ; Sangster SM; Moffat LD; Henderson MJ; Too CK
    J Cell Biochem; 2010 Aug; 110(5):1123-9. PubMed ID: 20544796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu.
    Schweiger S; Dorn S; Fuchs M; Köhler A; Matthes F; Müller EC; Wanker E; Schneider R; Krauß S
    J Biol Chem; 2014 Nov; 289(46):31805-31817. PubMed ID: 25278022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-box1 Domain of MID1 Interacts with the Ube2D1 E2 Enzyme Differently Than RING E3 Ligases.
    Kaur A; Gladu EM; Wright KM; Webb JA; Massiah MA
    Biochemistry; 2023 Mar; 62(5):1012-1025. PubMed ID: 36820504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective proteasomal degradation of the B'β subunit of protein phosphatase 2A by the E3 ubiquitin ligase adaptor Kelch-like 15.
    Oberg EA; Nifoussi SK; Gingras AC; Strack S
    J Biol Chem; 2012 Dec; 287(52):43378-89. PubMed ID: 23135275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulation reveals insights into the mechanism of unfolding by the A130T/V mutations within the MID1 zinc-binding Bbox1 domain.
    Zhao Y; Zeng C; Massiah MA
    PLoS One; 2015; 10(4):e0124377. PubMed ID: 25874572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of midline defect-causing mutation P151L in MID1 revealed.
    Nicholson LK
    FEBS J; 2017 Jul; 284(14):2167-2169. PubMed ID: 28714291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
    Yeung B; Ho KC; Yang X
    PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.
    Trockenbacher A; Suckow V; Foerster J; Winter J; Krauss S; Ropers HH; Schneider R; Schweiger S
    Nat Genet; 2001 Nov; 29(3):287-94. PubMed ID: 11685209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
    Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.